Combination of medication for treating hepatitis B and preparation method thereof

Abstract

The invention discloses a pharmaceutical composition for treating hepatitis B and a preparation method thereof. It is composed of clover, gardenia root, salvia, astragalus, white peony, turmeric, flavescens, hawthorn and other components. The preparation method comprises the following steps: weighing each raw material according to the proportion of the formula, crushing and grinding the above-mentioned medicine into coarse powder, decocting in water twice, the first time for 3 hours, the second time for 2 hours, filtering, concentrating the filtrate into a thick paste, drying , crushed through a 100-mesh sieve, mixed, moistened, softened, and taken out when agglomerated to make granular granules. The compound preparation prepared by the invention adopts an oral dosage form, which is convenient to use, has a good taste, and is easy to accept by patients; it has a strong effect of inhibiting and eliminating hepatitis B virus, and the HBsAg negative conversion rate can reach more than 55% after taking the medicine for 6 months; the treatment cost is low, compared with conventional treatment It can save more than 60% of the cost.

Description

technical field [0001] The invention relates to a Chinese patent medicine, in particular to a medicine composition for treating hepatitis B with Chinese medicine as a main component and a preparation method thereof. Background technique [0002] Hepatitis B is a disease with global distribution and great social harm. According to the incomplete survey of the World Health Organization, more than 1 million people die of hepatitis B disease every year in the world. my country is now a high-incidence area of ​​hepatitis B. The infection rate of hepatitis B virus in the national population is 42%-80%, and about 1 / 4 of the carriers of hepatitis B virus eventually develop into liver cirrhosis and primary liver cancer, accounting for about More than half of the world's hepatitis B patients. Hepatitis B is a multi-organ involvement, low function performance, complex pathogenesis, long course, easy to relapse, difficult to cure disease. Modern medicine still has no specific drug for...

AI Technical Summary

Problems solved by technology

New drugs such as Yiganning Granules, Yigan Jiedu Capsules, Jigucao Pills, and Yigan Powder, which are currently in clinical use, have unsatisfactory effects in treating hepatitis B, and their exact curative effects still need further research and verification.

Especially the treatment of chronic hepatitis B is very difficult, the key is to completely suppress and remove hepatitis B virus; adjust the body's immunity, protect liver cells, block chronicity (hepatic fibrosis), there is no ideal drug so far

Images